Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Avant receives further payment from Novartis for TP-10 development

Dec. 9, 1998

Patent covering cytokine trap technology issued to Regeneron

Dec. 7, 1998

StressGen's protein fusion vaccines elicit potent immune response without additional adjuvants

Dec. 7, 1998

Astra patents new pyrazolopyrimidinedione immunosuppressants

Dec. 4, 1998

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Dec. 3, 1998

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

Abbott purchases additional La Jolla stock

Dec. 1, 1998

OraVax files IND for colitis vaccine

Nov. 30, 1998

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...